Navigation Links
Study Questions Genetic Screening for Treatable Diseases
Date:9/18/2007

In some cases, parents opt for abortion when symptoms may be mild, study finds

TUESDAY, Sept. 18 (HealthDay News) -- Some Israeli couples with fetuses that tested positive for Gaucher disease, an inherited condition that can range from mild and treatable to severe, chose abortions, raising questions about the use of certain types of genetic screenings, a new study suggests.

The study authors also question the use of genetic screening for other kinds of mild hereditary disorders.

Gaucher disease (GD) includes three diseases caused by deficient activity of a certain enzyme. Common type 1 Gaucher disease often causes no symptoms and is usually not severe and can be treated, the researchers said.

According to the National Gaucher Foundation, the most common symptoms of the disease are enlarged livers and spleens; anemia; reduced platelets that can result in easy bruising and clotting difficulties; bone "infarctions" that can lead to damage to the shoulder or hip joints; and a generalized "demineralization" of the bones, or osteoporosis. This can lead to spontaneous fractures.

Gaucher disease is relatively common in Ashkenazi Jews, who have been offered screening worldwide and in Israel since 1995, according to background information in the study.

But the use of this screening is controversial, because the test does not fully predict the severity of the disease. Even so, some couples decide to abort a fetus if it tests positive for Gaucher disease, the researchers noted in the Sept. 19 issue of the Journal of the American Medical Association.

In the study, a team led by Shachar Zuckerman of Shaare Zedek Medical Center in Jerusalem analyzed data from 10 Israeli medical centers that offered Gaucher disease screening. From January 1995 to March 2003, there were about 28,893 people screened at the centers. Of those, there were 83 GD carrier couples. The GD carrier frequency was 5.7 per
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Karen Pallarito HealthDay Reporter ... wild day for Obamacare, two federal appeals courts arrived at ... provided to millions of Americans who bought health insurance through ... the matter is headed for a showdown before the U.S. ... U.S. Appeals Court for the District of Columbia Circuit said ...
(Date:7/23/2014)... The European Vitamins Market report explains ... and projection of revenue. The market in Europe is ... to $1,202.08 million by 2018, at a CAGR of ... TOC of the European Vitamins Market report, to get ... provides a glimpse of the segmentation in the European ...
(Date:7/23/2014)... The European Bio fertilizers Market Report defines ... analysis and forecast of revenue. The bio fertilizers market ... 2,566.4 million in 2012 to $4,582.2 million by 2017, ... , Browse through the TOC of the European Bio ... in-depth analysis provided. , http://www.micromarketmonitor.com/market/europe-bio-fertilizer-4637178345.html , ...
(Date:7/23/2014)... Bethesda, MD (July 23, 2014) Statins, a class ... reduce a patient,s risk of developing Barrett,s esophagus, according ... , the official journal of the American ... risk reduction with statin use. , "Patients who received ... of having Barrett,s esophagus compared to non-users," said study ...
(Date:7/23/2014)... July 23, 2014 According to a ... by Form Factor (Integrated Circuit IP, SOC IP), Design ... Application, Geography and Verification IP - Forecast & Analysis ... is expected to grow at a CAGR of 12.6% ... 2020. , Browse more than 76 market data tables ...
Breaking Medicine News(10 mins):Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Statin use decreases the risk of Barrett's esophagus 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 6
... a leading provider of laser vision correction services under ... center in Des,Moines, Iowa. This marks the 74th LasikPlus ... vision center in the state of Iowa.,LasikPlus vision centers ... Similar to other LasikPlus vision centers throughout the ...
... Highlights Myriad Opportunities for Using Wireless ... Efficiency and Accuracy of Patient Care, WALTHAM, Mass., ... intelligent wireless LANs (WLANs) for enterprises and,service providers, will ... Exhibition, taking place February 24-28 in Orlando, FL, to,showcase ...
... ECG Devices Help Healthcare Organizations Deliver Clinical ... Data Faster and ... Networks, the leading,global provider of intelligent wireless LANs (WLANs) ... Corporation,(Nasdaq: CSCX ) ( http://www.cardiacscience.com ), the leading ...
... of, CellCept Will Provide Effective Treatment Options, According ... ... Feb. 25 Decision Resources, one of the,world,s leading research ... entry and uptake of high-priced branded,agents will drive the systemic ...
... HealthVault Empowers Patients to Orchestrate Health ... ... the leading provider,of next generation healthcare connectivity solutions, today announced ... using Microsoft(R) HealthVault(TM), at the 2008 HIMSS,(Healthcare Information and Management ...
... Hyperion,Therapeutics, Inc. today announced that the first ... trial of AMMONUL(R) (sodium phenylacetate and sodium,benzoate) Injection ... hepatic,encephalopathy (HE). The randomized, double-blind study is designed ... standard of care in,hospitalized adults. The FDA has ...
Cached Medicine News:Health News:LCA-Vision Announces the Opening of its 74th LasikPlus Vision Center in Des Moines, Iowa 2Health News:Colubris Demonstrates Wide-Ranging Mobility Solutions for Healthcare 2Health News:Cardiac Science Corporation Selects Colubris Networks' Wireless Solution for its Portable Electrocardiograph 2Health News:Cardiac Science Corporation Selects Colubris Networks' Wireless Solution for its Portable Electrocardiograph 3Health News:Uptake of Branded Agents Will Drive the Systemic Lupus Erythematosus Drug Market to Quadruple to $1.4 Billion in 2016 2Health News:Kryptiq and Microsoft to Showcase Unprecedented Connectivity Between Consumers and Their Doctors at HIMSS '08 2Health News:Kryptiq and Microsoft to Showcase Unprecedented Connectivity Between Consumers and Their Doctors at HIMSS '08 3Health News:Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy 2Health News:Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy 3
(Date:7/23/2014)... YORK , July 23, 2014  When it comes ... Wagner is ready to roll out the red carpet. ... welcome an influx of HAL 9000-like robots into our human ... right now, there,s a pressing need to apply new technologies ... The worldwide market for medical robotics is expected to increase ...
(Date:7/23/2014)... July 23, 2014 Research and Markets ... Medical Gloves (Exam and Surgical) Markets Worldwide 2014" ... http://photos.prnewswire.com/prnh/20130307/600769 The purpose of this report ... Disposable Medical (Exam and Surgical) Gloves. The report discusses ... these products. Topics covered include product definitions, ...
(Date:7/23/2014)... July 23, 2014  Lightlake Therapeutics Inc. ("Lightlake") ... based on its expertise in opioid antagonists, announced ... drug application ("IND") with respect to its naloxone-based ... today that it has received an additional commitment ... part of the National Institutes of Health ("NIH"), ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3
... 2011 Assured Pharmacy (Pink Sheets: APHY ), ... than 3,000 sufferers of chronic pain announced that total sales ... 2010 were $1,514,984 which equates to $70,464 per business day. ... total sales of $1,348,344 for December 2009 which equates to ...
... 2011 BioDelivery Sciences International, Inc. ... outcome of a pre-Investigational New Drug (pre-IND) meeting ... on the development program for BEMA Buprenorphine/Naloxone, BDSI,s ... discussed is based on pharmacokinetic and safety data ...
Cached Medicine Technology:Assured Pharmacy Reports Same Store Sales for the Month of December 2010 2Assured Pharmacy Reports Same Store Sales for the Month of December 2010 3BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting 2BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting 3
Scorpio CR Knee is designed to address normal knee kinematics, range of motion (ROM) and polyethylene wear....
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
... Knee System has been ... refined with the aid ... and manufacturing technology. Its ... stability, function, performance and ...
... image guided surgery system offers full-featured ... design and use. It provides unparalleled ... localize critical anatomy and plan optimal ... surgeons an easy-to-use, technologically advanced approach ...
Medicine Products: